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D. Cloquet1, P. Hage1, L. Hanssens1, G. Casimir1. 1Children’s CF unit, Queen
Fabiola Children’s University Hospital, Brussels, Belgium
Introduction: The prognosis of CF patients is mainly inﬂuenced by lung affection.
Literature described that passive tobacco exposure increases the risk of pulmonary
infections and exacerbations, and the deterioration of lung function and nutritional
status.
Methods: We realized a survey in our CF unit to evaluate tobacco exposure in our
young patients and sensitize their parents about the harm of smoking.
CF unit nurse assessed tobacco exposure using a questionnaire addressed to parents
about smoking (age of ﬁrst cigarette use, number of pack per day, smoking during
pregnancy or child presence).
Results: Fifty nine patients were included [mean age:10.5 (0.4−18) years, 31
patients DF508/DF508, mean FEV1: 78.9% (±24), 5 patients chronically colonized
by Pseudomonas aeruginosa]. One hundred ten parents answered the questionnaire.
Thirty three percent of our patients (36/110) had at least one smoking parent (11%
smoking mother, 22% smoking father). The majority was smoker since adolescence.
Diagnosing CF pushed one parent to begin smoking while 6 other parents stopped
smoking after the diagnosis was made (p< 0.05).
Conclusions: CF patients’ parents seemed not to be enough informed about the
risks of tobacco exposure. They should receive the proper medical and psychological
support to encourage them quit smoking. In our survey, which is a small sample,
the majority afﬁrmed not smoking in the presence of their child but this could not
be conﬁrmed by a simple questionnaire. A larger cohort should be studied including
urinary nicotinine levels. Beside improvement in life expectancy brought by new
treatments available, smoking cessation should be considered in our management.
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Transition from pediatric to adult health care is a major life event for patients with a
chronic disease such as Cystic Fibrosis (CF). Transition care is the work undertaken
to prepare youth for the adult health care system and the management of their
health condition in adulthood. In Canada, CF transition care is often “championed”
by nurses, but it is unknown if, or to what extent, it is practiced in individual CF
clinics. We surveyed by questionnaire all 27 Canadian pediatric CF clinic nurse-
coordinators; 23 surveys (85%) were completed and analyzed.
All clinics reported transfer of patients to a distinct adult CF clinic at or about
age 18 years, with rare exceptions causing delay. Although almost half of the
pediatric clinics share one or more team members with their local adult clinic,
most responding clinics view adult CF care as distinct from pediatric care, and
approximately 75% of pediatric clinics engage in practices to help prepare their
patients for adult CF healthcare. However, of these, only 22% follow a formal
protocol with set goals, and documenting progress. The remainder either follow an
“informal” transition program with a wide variety of practices in whom it is not
possible to determine whether patients are receiving adequate preparation for adult
care; or (in 25% of clinics) no formal or informal transition program.
Survey results were presented at a Canadian CF nurse’s meeting. The commitment
to providing CF transition care was reafﬁrmed and CF clinics with formal protocols
were identiﬁed to serve as sources of information and inspiration for clinics
interested in formalizing their own approach to transition care. At least two CF
clinics are now in the process of developing their own programs. The survey has
identiﬁed gaps in CF care in Canada and served as a stimulus for improvement.
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S. Madge1, P. Agent1. 1Department of Cystic Fibrosis, Royal Brompton Hospital,
London, United Kingdom
Introduction: Urinary incontinence (UI) is well recognised in females with cystic
ﬁbrosis, however previous studies have not compared UI with quality of life (QoL).
Aim: To assess the impact of UI on QoL in women with CF.
Methods: Women with CF aged >17 yrs, attending the Royal Brompton Hospital
Adult CF Centre were invited to complete two anonymous postal questionnaires:
the CFQoL, and an assessment of occurrence, severity and impact of UI [using a
10 cm visual analogue scale (VAS)].
Results: Eighty-eight women aged 17 to 40+ yrs returned completed questionnaires.
Age of menarche (mean: 13.8 yrs, range 9−22 yrs), menopause (n = 5), and pregnan-
cies over 24 weeks gestation (n = 30) were recorded. 68% of women reported UI,
with 45% of these reporting that it occurred at any time and 5% experienced whole
bladder emptying during a chest infection. The VAS showed a mean score of 3.8,
with only 15% of respondents requesting help for their UI. Precipitating factors
included coughing (95%), sneezing (42%), laughing (38%) and hufﬁng (23%).
CFQoL results showed signiﬁcantly lower scores for women with UI compared
to those without, in a number of domains including chest symptoms (p = 0.006),
social function (p = 0.02), interpersonal relationships (p = 0.02), emotional responses
(p = 0.02) and body image (p = 0.02).
Conclusion: As with previous studies this population report a similar incidence
of UI (68%), with coughing being the commonest cause. Although perceived as a
relatively minor problem (low VAS score), women with UI report this as a signiﬁcant
impact on many aspects of their QoL. However, in spite of this impact on QoL,
many women are reluctant to be investigated or treated for UI. This may in part be
due to the perception of the problem compared to having CF and the already large
burden of treatment in CF.
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Adults with CF face challenges including the ongoing hope for lung transplanta-
tion (Tx) until the ﬁnal days of life. Little information is available to inform a
CF-speciﬁc, palliative care (PC) model. We performed a multi-phase study of the
differential patient, family and staff experiences to develop a PC CF model of care.
Surveys were derived from focus groups. Patients (n = 82), bereaved family members
(n = 18) and CF staff (n = 39) completed the surveys using analog scales. Patients
and families had less understanding of PC yet supported it as part of CF care.
All preferred a sequential rather than a parallel model, where PC and Tx planning
co-occur. Patients actively tried not to think about end of life as health deteriorated.
Information that was direct and honest, covering what to expect and options for
care and written information was supported. Timing of discussions were important
and at Tx referral was preferred. For staff, tensions between providing comfort to
patients vs active treatment in the hope of transplantation was apparent. Training to
manage the emotional aspects is needed. The development of a PC and CF model
of end of life care requires further information and counselling support, earlier in
the course of their illness than previously recognised. Differences in unmet needs,
expectations for care and clinical outcomes exist across the groups.
Supported by: The Australia CF Trust.
Table 1. Median score out of 10 or % predicted FEV1
Patients (82) Families (18) Staff (39)
PC part of care 8 10 10
PC knowledge limited 6 6 3
PC only if no Tx 2 4 1
CF team to initiate discussions 5 5 5
CF to discussions at FEV1 20% 30% 30%
